Empresa Curis, Inc. Nasdaq
Acciones
US2312691015
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Discovery and Development of Innovative Drug
100,0
%
| 10 | 100,0 % | 10 | 100,0 % | -1,37 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 10 | 100,0 % | -1,37 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
James Dentzer
CEO | Chief Executive Officer | 57 | 29/03/16 |
Diantha Duvall
DFI | Director of Finance/CFO | 52 | 26/07/22 |
Chief Tech/Sci/R&D Officer | - | 03/01/22 | |
Chief Tech/Sci/R&D Officer | - | 13/08/19 | |
Robert Martell
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/09/11 |
Mark W. Noel
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/03/01 |
Rachel Blasbalg
HRO | Human Resources Officer | - | 01/01/04 |
Dora Ferrari
PRN | Corporate Officer/Principal | - | 03/01/21 |
Nancy Soohoo
LAW | General Counsel | - | 01/01/03 |
Jonathan Zung
PRN | Corporate Officer/Principal | 59 | 01/05/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Kenneth Kaitin
BRD | Director/Board Member | 71 | 01/11/03 |
Martyn Greenacre
CHM | Chairman | 82 | 14/02/00 |
James Dentzer
CEO | Chief Executive Officer | 57 | 29/03/16 |
Marc Rubin
BRD | Director/Board Member | 69 | 03/06/10 |
Robert Martell
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/09/11 |
Anne Borgman
BRD | Director/Board Member | 56 | 01/10/22 |
John Hohneker
BRD | Director/Board Member | 64 | 02/12/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 5 894 085 | 5 883 204 ( 99,82 %) | 0 | 99,82 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+26,37 % | 48,16 mil M | |
-1,01 % | 41,73 mil M | |
+42,95 % | 41,03 mil M | |
-5,31 % | 28,77 mil M | |
+9,34 % | 25,59 mil M | |
-21,69 % | 18,96 mil M | |
+6,23 % | 12,92 mil M | |
+26,99 % | 12,03 mil M | |
-3,38 % | 11,77 mil M |